Armata Pharmaceuticals, Inc. (ARMP): As they advance through clinical trials...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	95
Posts	11595
Boards Moderated	0
Alias Born	12/27/2011

lesgetrich

Re: timberwolf7 post# 1300

Friday, 01/10/2020 8:45:59 AM

Friday, January 10, 2020 8:45:59 AM

As they advance through clinical trials the pps should grow as well. Hopefully the price will be over $5 before the next round of financing is required. JMO

Les

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ARMP News

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/04/2024 10:35:47 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:03:37 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/23/2024 09:17:19 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:55:39 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:55:01 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:54:48 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:54:29 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:54:25 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:53:36 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:53:29 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 02:53:27 AM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/15/2023 10:24:56 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/22/2023 11:17:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 12:00:15 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 11:30:59 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 11:15:29 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/03/2023 08:35:42 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/03/2023 08:34:24 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/24/2023 08:30:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2023 08:30:30 PM
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 07/11/2023 12:27:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2023 12:15:48 PM

More ARMP News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover